Efalizumab to Treat Uveitis

NCT00280826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

NIH

Sponsor class

Conditions

Uveitis
Macular Edema

Interventions

DRUG: Efalizumab

Sponsor

National Eye Institute (NEI)